:max_bytes(133120)/d2j5s05om7evfr.cloudfront.net/pubmed-llm-images/40012482/84cd3a22df598fa2397da463b6f0c161_wm.png)
Discovery of Safe COX-2 Inhibitors: Achieving Reduced Colitis Side Effects through Balanced COX Inhibition.
Summary: Finding the right pain relief is often a balancing act. For years, scientists focused on creating anti-inflammatory drugs that strictly blocked a specific protein called COX-2, hoping to stop pain without hurting the stomach. However, this hyper-focused approach turned out to cause other severe side effects, including colitis (inflammation of the colon). Now, researchers have shifted gears. Instead of blocking just COX-2, they are designing drugs that balance the inhibition of both COX-2 and its "cousin," COX-1. A new experimental compound, named 21d, has successfully hit this "sweet spot," offering potent pain relief with a much safer profile for the gut.
Tags
Colitis
Amino Acid Sequence
Cyclooxygenase 2 Inhibitors
Cyclooxygenase 2
Cyclooxygenase 1